Researchers at the Foundation have uncovered new insights into the complex link between dopamine and rest tremor in Parkinson ...

Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

“The positive results across all three Phase 3 TEMPO trials underscore the potential of tavapadon as a first-in-class D1/D5 ...

Parkinson’s disease is a progressive neurological disorder in which ongoing changes in the brain affect and interfere with ...

Tavapadon hit the primary endpoint in one phase 3 trial in April, before AbbVie closed the takeover, and racked up another victory in September. AbbVie completed the set Monday by reporting data from ...

Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May 28, 2024 — Regular high caffeine consumption affects dopamine function in patients with Parkinson's disease ...

Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...

New therapies that are less intrusive but more lasting than current interventions promise to arrest and even reverse neurodegeneration.

This pathway is heavily impacted by the loss of dopamine-producing neurons in Parkinson’s disease (PD). Targeting GPR6 ...

24, 2024 — Parkinson's disease, a debilitating nervous system ... neurological disorders attributed to dysfunctions in specific dopamine ... Alzheimer's Drug May Slow Down Cognitive Decline ...

Data from a late-stage study shows that treatment with flexible doses of ABBV's tavapadon reduced the burden of Parkinson's ...